Skip to main content

Broadhurst Vanessa's Form 4 filing

Johnson & Johnson (JNJ) · filed Feb 18, 2026

Accession no.
0000200406-26-000034
Filed
Feb 18, 2026
Trade date
Feb 13-17, 2026
Filing delay
5 days
Rule 10b5-1 plan
Not checked

This filing lists 9 non-derivative transactions and 6 derivative transactions. Open-market sales total $1.51M. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Broadhurst VanessaCIK 0001904787Officer (EVP, Global Corp Affairs)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 13, 2026Common StockMOption exerciseAcquired+408$0.00F1$024,002Direct
Feb 13, 2026Common StockFTax withholdingDisposed−144$244.55−$35,215.223,858Direct
Feb 13, 2026Common StockMOption exerciseAcquired+8,594$0.00F3$032,452Direct
Feb 13, 2026Common StockFTax withholdingDisposed−3,748$244.55−$916,573.428,704Direct
Feb 15, 2026Common StockMOption exerciseAcquired+492$0.00F5$029,196Direct
Feb 15, 2026Common StockFTax withholdingDisposed−252$243.45−$61,349.428,944Direct
Feb 15, 2026Common StockMOption exerciseAcquired+526$0.00F6$029,470Direct
Feb 15, 2026Common StockFTax withholdingDisposed−270$243.45−$65,731.529,200Direct
Feb 17, 2026Common StockSSaleDisposed−6,197$243.39F7−$1,508,287.8323,003Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 13, 2026Common StockMOption exerciseDisposed−408$0.00$00Direct
Feb 13, 2026Common StockMOption exerciseDisposed−8,594$0.00$00Direct
Feb 15, 2026Common StockMOption exerciseDisposed−492$0.00$0491Direct
Feb 15, 2026Common StockMOption exerciseDisposed−526$0.00$01,050Direct
Feb 15, 2026Common StockAGrant or awardAcquired+14,405$0.00$014,405Direct
Feb 15, 2026Common StockAGrant or awardAcquired+1,034$0.00$01,034Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

Referenced by the price of 1 transaction in Table I.

F3

Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting.

Referenced by the price of 1 transaction in Table I.

F5

Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

Referenced by the price of 1 transaction in Table I.

F6

Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

Referenced by the price of 1 transaction in Table I.

F7

This transaction was executed in multiple trades at prices ranging from $243.39 to $243.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)